Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Revenue | $0 | $1.6M | $7.8M | $582.0K |
| Cost of revenue | $4.2M | $17.7M | $82.0K | $1.8M |
| Gross profit | −$4.2M | −$16.1M | $7.7M | −$1.3M |
| Gross margin | — | -993.3% | 98.9% | -216.7% |
| R&D | $4.2M | $17.7M | $38.8M | $65.4M |
| Operating income | −$5.4M | −$18.7M | −$65.9M | −$95.1M |
| EBITDA | −$5.4M | −$18.5M | −$64.9M | −$94.2M |
| Net income | −$5.2M | −$19.2M | −$68.0M | −$88.5M |
| Net margin | — | -1187.2% | -871.6% | -15199.0% |
| EPS (diluted) | -0.51 | -6.67 | -3.78 | -2.23 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds ICVX.
No tracked institution reports a position in ICVX as of their last filing.
No one on the platform has traded ICVX yet.
| $801M |
| — |
| EXAIExscientia plc | $4.84 | — | $633M | — |
| HARPHarpoon Therapeutics, Inc. | $23.01 | +0.09% | $865M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$ICVX when their vaccine can be approved so that our CRV can be cashed? Anyone know about it?
View on StockTwits ↗$ICVX Icosavax, Inc. (NASDAQ:ICVX): A Promising Vaccine Developer Navigating the Competitive Landscape https://beyondspx.com/article/icosavax-inc-nasdaq-icvx-a-promising-vaccine-developer-navigating-the-competitive-landscape
View on StockTwits ↗$ATHE $CCCC $CADL $ADTX $ICVX you got $CADL right when it was 1 @dbr_island Let's hope you get $ATHE right ..200 to 300 % run incoming..😊
View on StockTwits ↗$ICVX Frazier Life Sciences Adds Industry Veteran and Serial Dealmaker, Adam Simpson, to Company Creation Team https://www.stocktitan.net/news/ICVX/frazier-life-sciences-adds-industry-veteran-and-serial-dealmaker-sav2daf83s7z.html
View on StockTwits ↗$ICVX Icosavax, Inc. (NASDAQ:ICVX): A Promising Vaccine Developer Navigating the Competitive Landscape http://beyondspx.com/2024/08/05/icosavax-inc-nasdaqicvx-a-promising-vaccine-developer-navigating-the-competitive-landscape/
View on StockTwits ↗$NVAX $ICVX was bought up for $2billion . This one truly deserves $10 -15 billion valuation . Do the research
View on StockTwits ↗$ICVX My wife's a pharmacist, and she's telling me to load up on this because of some new vaccine coming out 🤔. I gotta do some DD...
View on StockTwits ↗$ICVX trade halt (T12) was alerted to our Members at 7:50pm EST. Halt price: $15.39 Vol: 9.32M.
View on StockTwits ↗$ICVX new insider selling: 15000 shares. http://insiderbuyingselling.com/?t=ICVX
View on StockTwits ↗$ICVX: SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates $ICVX, CVLY, PGTI, KRTX https://www.chartmill.com/stock/quote/ICVX/news?utm_source=prnews-2024-1-9-shareholder-rights-investigation-halper-sadeh-llc-investigates-icvx-cvly-pgti-krtx&utm_medium=stocktwits&utm_campaign=pressRelease
View on StockTwits ↗Icosavax Insider Niranjan Kanesa-Thasan Sells $1,670,056.10 in $ICVX www.marketbeat.com/stocks/NASDAQ/ICVX/insider-trades/
View on StockTwits ↗Icosavax CEO Adam Simpson Sells $235,050.00 in $ICVX www.marketbeat.com/stocks/NASDAQ/ICVX/insider-trades/
View on StockTwits ↗$ICVX: SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates $ICVX, DSKE, RAIN, CNSL https://www.chartmill.com/stock/quote/ICVX/news?utm_source=prnews-2024-1-4-shareholder-investigation-halper-sadeh-llc-investigates-icvx-dske-rain-cnsl&utm_medium=stocktwits&utm_campaign=pressRelease
View on StockTwits ↗Signal alert: $ICVX - Overvalued https://stockinvest.us/l/sLKvA6KtVm
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.